Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine
Shanghai, China
NCT Number: NCT07128459
Patients with port-wine stains often develop macrocheilia, however, there is currently no effective treatment to significantly reduce the three-dimensional volume increase of the lips. This article presents a simplified "five-step" approach based on clinical experience, designed to assist inexperienced surgeons in performing this surgery effectively.
Looking for future studies?
Notify Me3 year–70 year
All sexes
Interventional
Not applicable
Shanghai, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1. Patients with port-wine macrocheilia. 2. Patients that underwent lip reduction surgery. 3. Age at surgery: ≥3 years and ≤70 years.
Exclusion criteria
1. Patients without port-wine macrocheilia. 2. Missing/incomplete baseline patient information. 3. Patients without postoperative photographs.
The Five-Step lip reduction surgery: (1) measurement and design; (2) incision and reduction of lip volume; (3) fixation and shape of the dry lip; (4) fixation and shape of the skin (the SMISS approach); (5) shaping of the wet lip mucosa (the SMISS approach).
Time frame: From enrollment to the end of treatment in 6 months to one year
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Other
Lip Reduction Surgery for Port-wine Macrocheilia: a Retrospective Single-center Clinical Study
Acronym: macrocheilia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07353385
Hemangioma, Hemangioma, Capillary
Xi’an, Shanxi, China
View Trial DetailsNCT00556946
Cardiovascular Abnormalities, Cardiovascular Diseases
Irvine, California, United States
View Trial DetailsNCT00573729
Cardiovascular Abnormalities, Cardiovascular Diseases
Irvine, California, United States
View Trial DetailsNCT01101360
Hemangioma, Hemangioma, Capillary
New York, United States
View Trial Details